Use of beta-blockers, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers to prevent atrial fibrillation Article Report uri icon

Overview

MeSH Major

  • Cardiovascular Diseases
  • Cause of Death
  • Electrocardiography
  • Signal Processing, Computer-Assisted

abstract

  • Atrial fibrillation, the most common cardiac arrhythmia in clinical practice, causes significant burden to patients and health care systems worldwide. Attention is being paid to prevention of atrial fibrillation using drugs that retard or prevent atrial fibrosis and arrhythmogenic remodeling, which lead to this arrhythmia. Agents that work through the renin-angiotensin-receptor system, the angiotensin-converting enzyme inhibitors and angiotensin receptor blockers, are showing promise in animal and human studies.

publication date

  • September 2006

Research

keywords

  • Report

Identity

Digital Object Identifier (DOI)

  • 10.1007/s11886-006-0075-1

PubMed ID

  • 16956451

Additional Document Info

start page

  • 356

end page

  • 64

volume

  • 8

number

  • 5